“Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative Surveys”

“Tobacco use continues to be a leading behavioral risk factor for cancer, chronic disease, and premature death. As the tobacco market landscape rapidly changes, patterns of use, including dual use (use of 2 products) and polyuse (use of 3 or more products), are evolving. Although the long-term health consequences of dual and polyuse are not well understood, the concurrent use of multiple tobacco products influences nicotine dependence, frequency of product use, and cessation intentions.”

AUTHORS: Jana L Hirschtick, Delvon T Mattingly, Beomyoung Cho, Luis Zavala Arciniega, David T Levy, Luz Maria Sanchez-Romero, Jihyoun Jeon, Stephanie R Land, Ritesh Mistry, Rafael Meza, Nancy L Fleischer   JOURNAL: American journal of health promotion

“The actual and anticipated effects of a menthol cigarette ban: a scoping review”

AUTHORS: Christopher J. Cadham, Luz Maria Sanchez-Romero, Nancy L. Fleischer, Ritesh Mistry, Jana L. Hirschtick, Rafael Meza, David T. Levy   JOURNAL: BMC Public Health   ABSTRACT: The United States (US) Food and Drug Administration (FDA), under the 2009 Family Smoking Prevention and Tobacco Control Act, banned characterizing flavors in cigarettes; however, mentholated tobacco products were exempt. Since 2009, over 20 US jurisdictions and numerous countries around the world have extended this restriction to menthol. Currently, the FDA is reconsidering its position on a nation-wide menthol cigarette ban. However, the effects of such a ban remain unclear...